GSE127988
Gene expression of the A375 melanoma cell line treated with RAF inhibitors Vemurafenib  and  time-course with EGF stimulation during Vemurafenib RAF inhibitor treatment alone or with the MEK inhibitor Cobimetinib
We treated for 24 hours the BRAF-V600E  melanoma cell line A375 with 7 doses of the RAF inhibitor Vemurafenib and, in a second experimental desing, we treated for 24 hours the BRAF-V600E  melanoma cell line A375 with Vemurafenib (1 uM) alone or in combination with the MEK inhibitor Cobimetinib (1 uM) and subsequently stimulated with EGF in a time-course of 7 time points for up to 8 hours (0, 0.5, 1, 2, 3, 4, 8 hours). Overall design: We measured mRNA levels of the A375 cell line treated for 24 hours with 7 doses of the RAF inhibitor Vemurafenib in the range 0.001-10 uM and, in a second experimental design, mRNA levels of the A375 cell line treated for 24 hours with the RAF inhibitor Vemurafenib (1 uM) alone or in combination with the MEK inhibitor Cobimetinib (1 uM) and subsequently stimulated with EGF (100 ng/mL) in a time-course up to 8 hours